Recordati SpA (MEX:RECN) FFO


MEX:RECN Recordati SpA MEX:RECN
71 GF Score
Price MXN1,019.79
GF Value MXN1,150.23
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Recordati SpA FFO?

FFO (Funds from operations) only applies to REITs.

MEX:RECN
71GF Score
Recordati SpA MEX:RECN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Recordati SpA (MEX:RECN) Overvalued in 2026?

Based on GuruFocus' analysis, Recordati SpA stock appears to be undervalued. The current stock price of MXN1,019.79 is trading 11.3% below its estimated GF Value™ of MXN1,150.23. GuruFocus considers Recordati SpA to be Modestly Undervalued.

Key valuation signals for MEX:RECN:

  • FFO:
  • GF Value™: MXN1,150.23 vs. price of MXN1,019.79 (11.3% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the MEX:RECN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Recordati SpA Business Description

Address Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is engaged in the development, production, and marketing of pharmaceutical products or of pharmaceutical chemicals. The Company operates in a broad and diverse context, which includes general medicine, specialist medicine, self-medication, and rare diseases. In addition, it is also active in the field of urology, with treatments for benign prostatic hyperplasia and male functional disorders, and in psychiatry. The Company's only operating segment is the Specialty & Primary Care segment. Its geographic areas are Europe, Australasia, America, and Africa.
71GF Score

Get the complete analysis for MEX:RECN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,019.79
Price
MXN1,150.23
GF Value